KEMPHARM, INC·4

Jan 11, 9:49 PM ET

Schafer Joshua 4

4 · KEMPHARM, INC · Filed Jan 11, 2023

Insider Transaction Report

Form 4
Period: 2023-01-09
Transactions
  • Award

    Stock Option (right to buy)

    2023-01-09+300,000300,000 total
    Exercise: $4.54Exp: 2033-01-08Common Stock (300,000 underlying)
Footnotes (1)
  • [F1]Grant to the Reporting Person of a stock option under the Issuer's 2023 Employment Inducement Award Plan (the "Plan"). 25% of the shares will vest on January 6, 2024 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4